On Demand 2018 Friday General Sessions

This collection covers general sessions from Friday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:

  • Anaphylaxis In-depth
  • Allergy-Immunology Physician Wellness: Challenges, Threats and Opportunities
  • Food Allergy Related Mortality
  • Has the Therapeutic Use of Oral Immunotherapy for Food Allergy Passed the Tipping Point?
  • Integrative Medicine 101: Lotions and Potions? or Possibilities?
  • Name that Rash: Serious Drug Rashes and Others
  • Phases of Allergy Practice
  • Tailoring Treatment Selection to Achieve Optimal Health Outcomes in Patients With HAE
  • What to Do When Your Patient is Allergic to Multiple Allergens for Which There are Sublingual FDA Approved Tablets
  • What to Do When Your Patients Reach the Yellow Zone

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 8.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Describe the personal and professional challenges to physician wellness at all stages of career.
  • Discuss the current and future threats to physician wellness for AI physicians
  • Describe approaches that can be done personally or professionally (including resources from ACAAI) that can build, maintain or repair physician wellness
  • Analyze risk vs benefit of early epinephrine use
  • Discuss topics relevant to the early phase of the practice of allergy.
  • Discuss topics relevant to the middle phase of the practice of allergy.
  • Discuss topics related to the late phase of the practice of allergy and transitioning out of practice.
  • Discuss the literature regarding sublingual immunotherapy efficacy and safety.
  • Discuss the literature regarding polysensitization and immunotherapy (both SCIT and SLIT).
  • Review the differential diagnosis of HAE and differentiate HAE from non-HAE angioedema.
  • Describe the limitations of emergency departments in management of acute HAE attacks and the allergist’s role in ensuring patients and other health care providers are prepared for acute attack management.
  • Describe current clinical trial evidence regarding the efficacy and safety of approved and emerging therapies for the prevention of HAE attacks.
  • Describe what is known of food allergy fatalities in the U.S., and explore questions around food allergy fatalities moving forwards.
  • Discuss food allergy-related death in an educated, empowered way, without fear or confusion.
  • Identify challenges and potential solutions when approaching the topic of food allergy-related mortality with families.
  • Recognize drug-induced rashes associated with high risk of morbidity and mortality.
  • Identify specific treatments for certain serious drug rashes.
  • Assess the current state-of-the-art in food oral immunotherapy.
  • Identify suitable patients for food oral immunotherapy.
  • Judge the readiness of the allergist’s practice to begin a food oral immunotherapy program.
  • Recognize the frequent practice of integrative (complementary and alternative) medicine.
  • Describe the potential risks and benefits associated with integrative medicine.
  • Provide a critical review of the literature supporting and opposing the use of integrative medicine to treat atopic disorders.
  • Identify risk factors for loss of asthma control in pediatric and adult patients.
  • Discuss the concept of dynamic dosing of inhaled corticosteroids for asthma.
  • Discuss potential differences in increasing inhaled corticosteroid dosing as yellow zone management in children versus adults.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (College) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, or evaluation of content for a CME activity. Financial disclosures are reviewed in advance, to ensure any potential conflicts of interest are resolved. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Specific disclosure information for the 2018 Annual Meeting is now available online.

Course summary
Available credit: 
  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Attendance
  • 1.50 MOC
Course opens: 
12/01/2018
Course expires: 
11/30/2021
Cost:
$0.00
Rating: 
0

Sami Bahna, MD, DrPH, FACAAI

Aleena Banerji, MD

Lisa Beck, MD

William E. Berger, MD, MBA, FACAAI

Michael Blaiss, MD, FACAAI

Julie Brown, MD

Stacy Dorris, MD

Mark S. Dykewicz, MD, FACAAI

Stanley Fineman, MD, MBA, FACAAI

Luz S. Fonacier, MD, FACAAI

Marianne Frieri, MD, PhD, FACAAI

Alan Goldsobel, MD, FACAAI

Erika Gonzalez Reyes, MD

Matthew Greenhawt, MD, MSc, MBA, FACAAI

Daniel Jackson, MD

David M. Lang, MD, FACAAI

Mitchell R. Lester, MD, FACAAI

 Jay Lieberman, MD, FACAAI

 Peter Lio, MD

Gailen Marshall, MD, PhD, FACAAI

Kathleen May, MD, FACAAI

Kevin P. McGrath, MD, FACAAI

Rajan Merchant, MD, FACAAI

Syed Shahzad Mustafa, MD, FACAAI

Harold S. Nelson, MD, FACAAI

Michael Nelson, MD, PhD

Maeve E. O’Connor, MD, FACAAI

Mark O'Hallaren, MD, FACAAI

John J. Oppenheimer, MD, FACAAI

Purvi Parikh, MD

Michael Pistiner, MD, MMSc, FACAAI

Jay M. Portnoy, MD, FACAAI

Melinda Rathkopf, MD, FACAAI

Marissa Shams, MD, FACAAI

Meagan Shepherd, MD, FACAAI

Ellen Sher, MD, FACAAI

Robert Sidbury, MD, MPH

James L. Sublett, MD, FACAAI

Dana V. Wallace, MD, FACAAI

Julie Wang, MD, FACAAI

Susan Waserman, MD, FACAAI

Richard L. Wasserman, MD, PhD, FACAAI

Robert A. Wood, MD

Available Credit

  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Attendance
  • 1.50 MOC

Accreditation Period

Course opens: 
12/01/2018
Course expires: 
11/30/2021

Price

Cost:
$0.00
Please login or create an account to take this course.